Domain v of β2-Glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318

被引:24
作者
Shi, T
Giannakopoulos, B
Iverson, GM
Cockerill, KA
Linnik, MD
Krilis, SA
机构
[1] Univ New S Wales, St George Hosp, Dept Med, Dept Immunol Allergy & Infect Dis, Sydney, NSW 2217, Australia
[2] La Jolla Pharmaceut Corp, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.M410291200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fifth domain (DV) of beta(2)-glycoprotein I (beta(2)GPI) is important for binding a number of ligands including phospholipids and factor XI (FXI). beta(2)GPI is proteolytically cleaved in DV by plasmin but not by thrombin, VIIa, tissue plasminogen activator, or uPA. Following proteolytic cleavage of DV by plasmin, beta(2)GPI retains binding to FXI but not to phospholipids. Native beta(2)GPI, but not cleaved beta(2)GPI, inhibits activation of FXI by thrombin and factor XIIa, attenuating a positive feedback mechanism for additional thrombin generation. In this report, we have defined the FXI/FXIa binding site on beta(2)GPI using site-directed mutagenesis. We show that the positively charged residues Lys(284), Lys(286), and Lys(287) in DV are essential for the interaction of beta(2)GPI with FXI/FXIa. We also demonstrate that FXIa proteolytically cleaves beta(2)GPI at Lys(317)- Thr(318) in DV. Thus, FXIa cleavage of beta(2)GPI in vivo during thrombus formation may accelerate FXI activation by decreasing the inhibitory effect of beta(2)GPI.
引用
收藏
页码:907 / 912
页数:6
相关论文
共 48 条
[1]   RETRACTED: Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa (Retracted article. see vol 282, pg 29067, 2007) [J].
Baglia, FA ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20514-20519
[2]   RETRACTED: Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin (Retracted Article. See vol 46, pg 12886, 2007) [J].
Baglia, FA ;
Walsh, PN .
BIOCHEMISTRY, 1998, 37 (08) :2271-2281
[3]   Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation [J].
Baird, TR ;
Walsh, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :28498-28503
[4]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[5]   Adhesion mechanism of human β2-glycoprotein I to phospholipids based on its crystal structure [J].
Bouma, B ;
de Groot, PG ;
van den Elsen, JMH ;
Ravelli, RBG ;
Schouten, A ;
Simmelink, MJA ;
Derksen, RHWM ;
Kroon, J ;
Gros, P .
EMBO JOURNAL, 1999, 18 (19) :5166-5174
[6]  
Bouma BN, 1999, THROMB HAEMOSTASIS, V82, P243
[7]  
Del Papa N, 1998, J IMMUNOL, V160, P5572
[8]   ACTIVATION OF HUMAN FACTOR-9 (CHRISTMAS-FACTOR) [J].
DISCIPIO, RG ;
KURACHI, K ;
DAVIE, EW .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (06) :1528-1538
[9]   Model for a factor IX activation complex on blood platelets: dimeric conformation of factor IXa is essential [J].
Gailani, D ;
Ho, D ;
Sun, MF ;
Cheng, QF ;
Walsh, PN .
BLOOD, 2001, 97 (10) :3117-3122
[10]   Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature [J].
Galli, M ;
Luciani, D ;
Bertolini, G ;
Barbui, T .
BLOOD, 2003, 101 (05) :1827-1832